PETER RIEPENHAUSEN Insider Trading $HRTX HERON THERAPEUTICS, INC. /DE/
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for PETER RIEPENHAUSEN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of PETER RIEPENHAUSEN. PETER RIEPENHAUSEN is Director in HERON THERAPEUTICS, INC. /DE/ ($HRTX).
PETER RIEPENHAUSEN in HERON THERAPEUTICS, INC. /DE/
Trading Symbol: HRTXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PETER RIEPENHAUSEN: Director
Holdings: 36,270 shares
Latest Transaction: May 24 2007
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of PETER RIEPENHAUSEN in HERON THERAPEUTICS, INC. /DE/
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 24 2007 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Option Exercise | A | 0.75 | 10,000 | 7,500 | 10,000 | |
May 24 2007 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Grant | A | 0.01 | 12,000 | 120 | 36,270 | 24.3 K to 36.3 K (+49.44 %) |
Mar 30 2007 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Buy | P | 1.28 | 15,000 | 19,167 | 179,332 | 164.3 K to 179.3 K (+9.13 %) |
Aug 14 2006 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Buy | J | 0.00 | 1,714 | 0 | 164,332 | 162.6 K to 164.3 K (+1.05 %) |
Aug 14 2006 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Sell | J | 0.00 | 1,714 | 0 | 24,270 | 26 K to 24.3 K (-6.60 %) |
Aug 14 2006 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Grant | A | 1.75 | 1,714 | 3,000 | 25,984 | 24.3 K to 26 K (+7.06 %) |
Jun 01 2006 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Option Exercise | A | 1.74 | 10,000 | 17,400 | 10,000 | |
Jun 01 2006 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Grant | A | 0.01 | 5,000 | 50 | 24,270 | 19.3 K to 24.3 K (+25.95 %) |
May 15 2006 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Buy | J | 0.00 | 2,250 | 0 | 162,618 | 160.4 K to 162.6 K (+1.40 %) |
May 15 2006 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Sell | J | 0.00 | 2,250 | 0 | 19,270 | 21.5 K to 19.3 K (-10.46 %) |
May 15 2006 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Grant | A | 2.00 | 2,250 | 4,500 | 21,520 | 19.3 K to 21.5 K (+11.68 %) |
Mar 20 2006 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Buy | J | 0.00 | 2,614 | 0 | 160,368 | 157.8 K to 160.4 K (+1.66 %) |
Mar 20 2006 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Sell | J | 0.00 | 2,614 | 0 | 19,270 | 21.9 K to 19.3 K (-11.94 %) |
Mar 20 2006 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Grant | A | 1.53 | 2,614 | 3,999 | 21,884 | 19.3 K to 21.9 K (+13.57 %) |
Nov 07 2005 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Buy | J | 0.00 | 2,586 | 0 | 157,754 | 155.2 K to 157.8 K (+1.67 %) |
Nov 07 2005 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Sell | J | 0.00 | 2,586 | 0 | 19,270 | 21.9 K to 19.3 K (-11.83 %) |
Nov 07 2005 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Grant | A | 1.74 | 2,586 | 4,500 | 21,856 | 19.3 K to 21.9 K (+13.42 %) |
Aug 30 2005 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Buy | P | 1.50 | 10,000 | 15,000 | 155,168 | 145.2 K to 155.2 K (+6.89 %) |
Aug 11 2005 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Buy | J | 0.00 | 2,400 | 0 | 145,168 | 142.8 K to 145.2 K (+1.68 %) |
Aug 11 2005 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Sell | J | 0.00 | 2,400 | 0 | 19,270 | 21.7 K to 19.3 K (-11.08 %) |
Aug 11 2005 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Grant | A | 1.66 | 2,400 | 3,984 | 21,670 | 19.3 K to 21.7 K (+12.45 %) |
May 26 2005 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Option Exercise | A | 1.60 | 10,000 | 16,000 | 10,000 | |
May 12 2005 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Buy | J | 0.00 | 4,167 | 0 | 142,768 | 138.6 K to 142.8 K (+3.01 %) |
May 12 2005 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Sell | J | 0.00 | 4,167 | 0 | 19,270 | 23.4 K to 19.3 K (-17.78 %) |
May 12 2005 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Grant | A | 1.44 | 4,167 | 6,000 | 23,437 | 19.3 K to 23.4 K (+21.62 %) |
Mar 15 2005 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Buy | J | 0.00 | 2,424 | 0 | 138,601 | 136.2 K to 138.6 K (+1.78 %) |
Mar 15 2005 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Sell | J | 0.00 | 2,424 | 0 | 19,270 | 21.7 K to 19.3 K (-11.17 %) |
Mar 15 2005 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Grant | A | 1.65 | 2,424 | 4,000 | 21,694 | 19.3 K to 21.7 K (+12.58 %) |
Nov 17 2004 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Buy | J | 0.00 | 3,704 | 0 | 136,177 | 132.5 K to 136.2 K (+2.80 %) |
Nov 17 2004 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Sell | J | 0.00 | 3,704 | 0 | 19,270 | 23 K to 19.3 K (-16.12 %) |
Nov 17 2004 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Grant | A | 1.35 | 3,704 | 5,000 | 22,974 | 19.3 K to 23 K (+19.22 %) |
Sep 02 2004 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Buy | J | 0.00 | 1,194 | 0 | 132,473 | 131.3 K to 132.5 K (+0.91 %) |
Sep 02 2004 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Sell | J | 0.00 | 1,194 | 0 | 19,270 | 20.5 K to 19.3 K (-5.83 %) |
Sep 02 2004 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Grant | A | 3.35 | 1,194 | 4,000 | 20,464 | 19.3 K to 20.5 K (+6.20 %) |
Jun 01 2004 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Option Exercise | M | 1.21 | 10,000 | 12,100 | 0 | |
Jun 01 2004 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Buy | J | 0.00 | 10,000 | 0 | 131,279 | 121.3 K to 131.3 K (+8.25 %) |
Jun 01 2004 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Sell | J | 0.00 | 10,000 | 0 | 19,270 | 29.3 K to 19.3 K (-34.16 %) |
Jun 01 2004 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Buy | M | 1.21 | 10,000 | 12,100 | 29,270 | 19.3 K to 29.3 K (+51.89 %) |
Jun 01 2004 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Option Exercise | M | 1.21 | 10,000 | 12,100 | 0 | |
Jun 01 2004 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Buy | J | 0.00 | 10,000 | 0 | 131,279 | 121.3 K to 131.3 K (+8.25 %) |
Jun 01 2004 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Sell | J | 0.00 | 10,000 | 0 | 19,270 | 29.3 K to 19.3 K (-34.16 %) |
Jun 01 2004 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Buy | M | 1.21 | 10,000 | 12,100 | 29,270 | 19.3 K to 29.3 K (+51.89 %) |
May 26 2004 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Option Exercise | A | 2.94 | 10,000 | 29,390 | 10,000 | |
May 26 2004 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Buy | J | 0.00 | 1,502 | 0 | 121,279 | 119.8 K to 121.3 K (+1.25 %) |
May 26 2004 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Buy | J | 0.00 | 1,633 | 0 | 119,777 | 118.1 K to 119.8 K (+1.38 %) |
May 26 2004 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Sell | J | 0.00 | 1,502 | 0 | 19,270 | 20.8 K to 19.3 K (-7.23 %) |
May 26 2004 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Sell | J | 0.00 | 1,633 | 0 | 20,772 | 22.4 K to 20.8 K (-7.29 %) |
May 12 2004 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Grant | A | 3.33 | 1,502 | 5,002 | 22,405 | 20.9 K to 22.4 K (+7.19 %) |
May 12 2004 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Grant | A | 2.45 | 1,633 | 4,001 | 20,903 | 19.3 K to 20.9 K (+8.47 %) |
Mar 25 2004 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Option Exercise | M | 2.95 | 10,000 | 29,500 | 0 | |
Mar 25 2004 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Option Exercise | M | 2.34 | 10,000 | 23,400 | 0 | |
Mar 25 2004 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Buy | J | 0.00 | 20,000 | 0 | 118,144 | 98.1 K to 118.1 K (+20.38 %) |
Mar 25 2004 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Sell | J | 0.00 | 20,000 | 0 | 19,270 | 39.3 K to 19.3 K (-50.93 %) |
Mar 25 2004 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Buy | M | 2.34 | 10,000 | 23,400 | 39,270 | 29.3 K to 39.3 K (+34.16 %) |
Mar 25 2004 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Buy | M | 2.95 | 10,000 | 29,500 | 29,270 | 19.3 K to 29.3 K (+51.89 %) |
Nov 20 2003 | HRTX | HERON THERAPEUTICS ... | RIEPENHAUSEN PETER | Director | Grant | A | 2.23 | 1,794 | 4,001 | 98,144 | 96.4 K to 98.1 K (+1.86 %) |
Page: 1